"AMBS" - Most undervalued micro cap. Recently announced a deal with Becton Dickinson to develop its diagnostic test to detect early stage Alzheimer's. Potential $500,000,000 annual market.
Dr. Joseph Rubinfeld, one of the co-founders of Amgen, is on the company's advisory board.
Currently trading under a nickle.